Open access · US-GOV via ClinicalTrials.gov Clinical trial

A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults

Authors not listed

dsm-firmenich Switzerland AG · 2025

Dysbiosis Human Randomized controlled trial

Abstract

To assess the effect of 3 months of daily consumption of a postbiotic (inactivated lactic acid bacteria) Humiome® Post LB on stress measured by the Depression Anxiety Stress Scale-21 (DASS-21) adjusted on baseline in study participants when compared to placebo

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source: ClinicalTrials.gov
Canonical: link ↗
Fetched: 2026-05-29 MST

Cite this

APA

Anonymous. (2025). A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults. <em>dsm-firmenich Switzerland AG</em>. https://clinicaltrials.gov/study/NCT07110896

Vancouver

Anonymous. A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults. dsm-firmenich Switzerland AG. 2025.

BibTeX

@misc{anon2025ARando, title = {A Randomized, Placebo-controlled, Double-blind Clinical Study to Evaluate the Effect of Humiome® Post LB on Stress, Anxiety, and Cognition in Aging Adults}, author = {Anonymous}, journal = {dsm-firmenich Switzerland AG}, year = {2025}, }